(The GERD patient population is a largely untapped surgical market; see chart entitled, “Total Potential Market for Endoscopic GERD Therapies”)
Physicians from UT Southwestern Medical Center and engineers from UT Arlington have collaborated to develop a new technology for detecting the occurrence of heartburn and gastroesophageal reflux disease (GERD). Presented in May at the Digestive Disease [...]
Exhibit ES-8: Selected Sealant Product Companies and Their Strategies
Company
Products and Prices
Strategy
Focal
division of Genzyme
Biosurgery
Focal
Seal L $30 per ml
Available for lung resections in Europe and as an adjunct for non-hemostasis
sealing in the USA. Focal exploiting light activated hydrogel IP.
Focal is strategically focused on exploiting unique sealant
capability of its products in neurological, cardiovascular,
gastrointestinal, and thoracic applications.
Angiotech
CoStasis
(Dynastat) [...]
Not every start-up succeeds. But every single successful medical technology company was once a start-up. From a primary consideration, start-up companies have been founded based on: (1) what technologies they consider possible, and (2) the need for clinical solutions to problems that exist in health care. For this reason, we look at the range of [...]
